RIPE-KG · Version 1.1.0 · Resource
ripekg:work/10.1093%2Fannonc%2Fmdr400
https://w3id.org/ripe/ripe-kg/work/10.1093%2Fannonc%2Fmdr400
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.1093%2Fannonc%2Fmdr400Celecoxib can prevent capecitabinerelated hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial |
prism:doi |
10.1093/annonc/mdr400 |
ripekg:work/10.1093%2Fannonc%2Fmdr400Celecoxib can prevent capecitabinerelated hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial |
dcterms:title |
Celecoxib can prevent capecitabinerelated hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial |
ripekg:work/10.1093%2Fannonc%2Fmdr400Celecoxib can prevent capecitabinerelated hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial |
rdf:type |
node1 |
ripekg:work/10.1093%2Fannonc%2Fmdr400Celecoxib can prevent capecitabinerelated hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1093%2Fannonc%2Fmdr400Celecoxib can prevent capecitabinerelated hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial |
rdf:type |
rdfs:Resource |
ripekg:work/10.1093%2Fannonc%2Fmdr400Celecoxib can prevent capecitabinerelated hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial |
rdf:type |
owl:Thing |
ripekg:work/10.1093%2Fannonc%2Fmdr400Celecoxib can prevent capecitabinerelated hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial |
rdf:type |
prov:Entity |
ripekg:work/10.1093%2Fannonc%2Fmdr400Celecoxib can prevent capecitabinerelated hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1093%2Fannonc%2Fmdr400Celecoxib can prevent capecitabinerelated hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial |
owl:sameAs |
https://semopenalex.org/work/W2135498562 |
ripekg:work/10.1136%2Fbmj-2025-084290Effect of methylcobalamin on capecitabine induced hand-foot syndrome in patients with HER2 negative early breast cancer: multicentre, double blind, randomised, placebo controlled, phase 3 trial |
http://purl.org/spar/cito/cites |
ripekg:work/10.1093%2Fannonc%2Fmdr400Celecoxib can prevent capecitabinerelated hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial |
ripekg:work/10.1136%2Fbmj-2025-084290Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1093%2Fannonc%2Fmdr400Celecoxib can prevent capecitabinerelated hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial |